qER Neurosuite

FDA, CE & Health Canada | Neuro | CT | Amplifier Partner

Amplifier Marketplace Radiology

Description of use

Neurosuite/qER-ER is real-time detection, triage and notification tool that analyses non-contrast head CT scans for critical abnormalities including intracranial hemorrhage, fracture, mass effect, midline shift, cranial fracture, infarct, and cerebral atrophy.

Key Findings: ICH (and subtypes, midline shift, mass effect, cranial fractures) + qQuant which is (Quantification of ICH and subtypes, lateral ventricles, and midline shift) + detection of infarcts and ASPECTS scoring, LVO detection

Benefits of the AI model:

  • Improved accuracy of clinical diagnosis
  • Drastically reduces the time to reporting critical scans by auto-triaging and flagging them in the work-list - reduction of TAT by 97%
  • By auto-detecting intracranial hemorrhage, infarcts, qER model can ensure real-time care of stroke patients who are time sensitive
  • Reduced LoS in ER

 

How is the application integrated?

  • Results displayed in IDS7: Yes
  • DICOM output: DICOM SC, DICOM GSPS, Encapsulated PDF
  • Worklist integration: Yes
  • Pre-populated reports: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

qCT Lung Cancer
CE & Health Canada | CT
Early detection of lung cancer and the management of lung nodules on chest CT scans by detecting lung nodules ranging from 3mm to 30mm with capabilities including volumetry, diameter, localization, texture, calcification, spiculation, malignancy risk, and progression monitoring via adaptable AI.
qXR Lung Cancer
CE & Health Canada | X-ray
Incidental detection of lung cancer through the identification of lung nodules between 6mm to 30mm including detection and visualization of pulmonary nodules and masses, assigning malignancy scores, and providing pre-populated reports.
qXR Heart Failure
FDA, CE & Health Canada | X-ray
Identifying high-risk heart failure patients from incidental pathways for opportunistic screening by detecting pleural effusion, cardiomegaly and assessing cardiothoracic ratio.
qXR Rad-assist
FDA, CE & Health Canada | X-ray
Segregation of worklists as unremarkable and remarkable across 40+ findings within lungs, pleura, mediastinum, bones, diaphragm, and heart along with an automated editable radiological report significantly reducing time to diagnosis and enabling early detection.
qXR Emergency Room
FDA, CE & Health Canada | X-ray
Abnormal, Atelectasis, Non Aortic Calcification, Cardiomegaly, Cavity, Consolidation, Hyper Inflation, Fibrosis, Opacity, Pleural Effusion, Prominence in Hilar Region, Reticulonodular Pattern, Scoliosis, Tracheal shift, Nodule, Pneumothorax

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.